133 related articles for article (PubMed ID: 7990977)
1. Effects of neuropeptide Y and vasoactive intestinal peptide on human venous smooth muscle in vivo.
Wolzt M; Gerschlager W; Zweytick B; Jilma B; Riemer H; Sertl K; Eichler HG
Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):194-200. PubMed ID: 7990977
[TBL] [Abstract][Full Text] [Related]
2. Innervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide.
Edvinsson L; Håkanson R; Steen S; Sundler F; Uddman R; Wahlestedt C
Regul Pept; 1985 Sep; 12(1):67-79. PubMed ID: 2416012
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP.
Erlinge D; Brunkwall J; Edvinsson L
Regul Pept; 1994 Mar; 50(3):259-65. PubMed ID: 8016410
[TBL] [Abstract][Full Text] [Related]
4. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
5. Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium.
Pernow J
Br J Pharmacol; 1989 Jul; 97(3):983-9. PubMed ID: 2474355
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the inhibitory action of neuropeptide Y (NPY) in guinea-pig trachea by the C-terminal fragment NPY (2-36).
Taoudi Benchekroun M; St-Pierre S; Fournier A; Cadieux A
Br J Pharmacol; 1993 Aug; 109(4):902-4. PubMed ID: 8401942
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors.
Bernet F; Bernard J; Laborie C; Montel V; Maubert E; Dupouy JP
Neurosci Lett; 1994 Jan; 166(1):109-12. PubMed ID: 8190350
[TBL] [Abstract][Full Text] [Related]
8. The effects of age on human venous responsiveness to neuropeptide Y.
Lambert ML; Callow ID; Feng QP; Arnold JM
Br J Clin Pharmacol; 1999 Jan; 47(1):83-9. PubMed ID: 10073744
[TBL] [Abstract][Full Text] [Related]
9. Interaction of NPY and VIP in regulation of myometrial blood flow and mechanical activity.
Tenmoku S; Ottesen B; O'Hare MM; Sheikh S; Bardrum B; Hansen B; Walker B; Murphy RF; Schwartz TW
Peptides; 1988; 9(2):269-75. PubMed ID: 3375135
[TBL] [Abstract][Full Text] [Related]
10. Control of porcine lacrimal gland secretion by non-cholinergic, non-adrenergic nerves: effects of electrical field stimulation, VIP and NPY.
Adeghate EA; Singh J; Howarth FC; Burrows S
Brain Res; 1997 May; 758(1-2):127-35. PubMed ID: 9203541
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control.
Lundberg JM; Anggård A; Pernow J; Hökfelt T
Cell Tissue Res; 1985; 239(1):9-18. PubMed ID: 2578317
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y and vasoactive intestinal polypeptide in cerebral arteries of the rat: relationships between innervation pattern and mechanical response.
Brayden JE; Conway MA
Regul Pept; 1988 Aug; 22(3):253-65. PubMed ID: 3175062
[TBL] [Abstract][Full Text] [Related]
13. [Peptide innervation of the penis].
Wespes E; Shiffmann S; Schulman CC; Vanderhaeghen JJ
Acta Urol Belg; 1990; 58(2):29-41. PubMed ID: 2073037
[TBL] [Abstract][Full Text] [Related]
14. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
15. Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility.
Saetrum Opgaard O; Gulbenkian S; Bergdahl A; Barroso CP; Andrade NC; Polak JM; Queiroz e Melo JQ; Edvinsson L
Cardiovasc Res; 1995 Apr; 29(4):463-8. PubMed ID: 7540955
[TBL] [Abstract][Full Text] [Related]
16. Vascular effects of neuropeptides on nasal mucosa.
Ichimura K; Mineda H; Seki A
Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):289-93. PubMed ID: 2454064
[TBL] [Abstract][Full Text] [Related]
17. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
[TBL] [Abstract][Full Text] [Related]
18. HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis.
Kim J; Ruff M; Karwatowska-Prokopczuk E; Hunt L; Ji H; Pert CB; Zukowska-Grojec Z
Regul Pept; 1998 Sep; 75-76():201-5. PubMed ID: 9802410
[TBL] [Abstract][Full Text] [Related]
19. Effects of serotonin and noradrenaline on superficial hand veins in patients with primary hypertension and in healthy volunteers.
Wolzt M; Schmidt E; Wagner B; Schuller-Petrovic S; Kyrle PA; Eichler HG
Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):490-5. PubMed ID: 1470220
[TBL] [Abstract][Full Text] [Related]
20. Interaction of noradrenaline, NPY and VIP with the neurogenic cholinergic response of the rat uterine cervix in vitro.
Stjernquist M; Owman C
Acta Physiol Scand; 1987 Dec; 131(4):553-62. PubMed ID: 3327363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
